Modafinil: an anti-relapse medication.
Tahsili-Fahadan
Pouya
P
Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA.
Malcolm
Robert
R
Aston-Jones
Gary
G
D000818:Animals; D001559:Benzhydryl Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D000077408:Modafinil; D011877:Radionuclide Imaging; D018094:Receptors, Metabotropic Glutamate / Q000378:metabolism; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000378:metabolism
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D018094:Receptors, Metabotropic Glutamate; C108822:metabotropic glutamate receptor 2; C102718:metabotropic glutamate receptor 3; D000077408:Modafinil